Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) were down 2.9% on Tuesday . The stock traded as low as C$0.17 and last traded at C$0.17. Approximately 105,487 shares traded hands during trading, a decline of 64% from the average daily volume of 289,703 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Price Performance
The company has a 50 day moving average of C$0.11 and a two-hundred day moving average of C$0.13. The firm has a market cap of C$27.57 million, a P/E ratio of -5.25 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Investing in the High PE Growth Stocks
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
- 10 Best Airline Stocks to Buy
- Is a Bottom Finally Forming in Rocket Lab Stock?
- How to Capture the Benefits of Dividend Increases
- Gold Rally vs. Oil Surge: Where Investors Are Betting Next
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
